Expression of β-dystroglycan is reduced or absent in many human carcinomas
✍ Scribed by S S Cross; J Lippitt; A Mitchell; F Hollingsbury; S P Balasubramanian; M W R Reed; C Eaton; J W Catto; F Hamdy; S J Winder
- Book ID
- 110092734
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 732 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0309-0167
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Transforming growth factor‐β (TGF‐β) inhibits epithelial cell proliferation. Inactivation of the TGF‐β signaling pathway is thought to play a role in tumorigenesis. Our purpose was to clarify the correlation between TGF‐β receptors or TGF‐β1 expression and the clinicopathologic characte
## Abstract The effects of EGF and TGF‐β1 on the proliferation of 2 ovarian carcinoma cell lines (IGROV1 and OVCCR1) were evaluated. The cell lines were adapted to grow in a restricted serum (0.5%) medium. EGF was required for proliferation of both ovarian cell lines. Low doses of TGF‐β1 inhibited
## Abstract The ErbB family of receptor kinases is composed of four members: epidermal growth factor receptor (EGFR/ErbB1), ErbB2/neu, ErbB3, and ErbB4. Amplification of the ErbB2/neu is found in about 30% of breast cancer patients and is associated with a poor prognosis. Heregulin (HRG) activates
In our study, we investigated molecular mechanisms of increased adenoviral transduction efficacy in cisplatin-resistant human laryngeal carcinoma cells CA3 ST as compared to parental cells HEp2. Using reverse transcription-PCR, the genes potentially implicated in adenoviral entry were screened. In c